Additionally, in many of the primary cancer and metastatic (data not shown) tissues in this study there was more nuclear immunoreactivity for SHARP-2 at the periphery of the tumour than was evident in the centre of the tumour (Figure 5B). Here, BHLHE40 is linked to cancer.